The role of sulfhydryl groups in three models of inflammatory disease.
D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy*; D002351:Carrageenan; D003436:Croton Oil; D003520:Cyclophosphamide / Q000627:therapeutic use; D003545:Cysteine / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004220:Disulfides / Q000097:blood; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005033:Ethylmaleimide / Q000037:antagonists & inhibitors; D005620:Freund's Adjuvant; D006023:Glycoproteins / Q000097:blood; D006099:Granuloma / Q000139:chemically induced / Q000188:drug therapy*; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D051381:Rats; D013438:Sulfhydryl Compounds / Q000097:blood / Q000627:therapeutic use*
D004220:Disulfides; D006023:Glycoproteins; D013438:Sulfhydryl Compounds; D003907:Dexamethasone; D003436:Croton Oil; D003520:Cyclophosphamide; D002351:Carrageenan; D005620:Freund's Adjuvant; D010396:Penicillamine; D003545:Cysteine; D005033:Ethylmaleimide; D007213:Indomethacin